Search - tctmd.com

Displaying 661 - 680 of 1004

Sort: Relevancy | Date

Presentation TCT 2017

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Presenter: Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Presenter: Somjot S. Brar, Roxana Mehran, Hitinder S. Gurm

November 01, 2017

Presentation TCT 2017

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Presenter: Somjot S. Brar, Roxana Mehran, Ran Kornowski

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Presenter: Somjot S. Brar, Roxana Mehran, Anand Prasad

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Presenter: Somjot S. Brar, Roxana Mehran, Michael P. Flaherty

November 01, 2017

Presentation TCT 2017

Feasibility of PCI With No Contrast

Presenter: Patricia J. Best, Somjot S. Brar, Ziad A. Ali

November 01, 2017

Presentation TCT 2017

Strategies to Optimize Hydration for CIN Prevention

Presenter: Patricia J. Best, Somjot S. Brar

November 01, 2017

Presentation TCT 2017

Contrast Reduction Strategies in the Patient With CKD

Presenter: Patricia J. Best, Somjot S. Brar, Roxana Mehran

November 01, 2017

Presentation TCT 2017

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Presenter: Patricia J. Best, Somjot S. Brar, Hitinder S. Gurm

November 01, 2017

Presentation TCT 2017

Contrast Induced Nephropathy: Why Does It Matter?

Presenter: Patricia J. Best, Somjot S. Brar, Carlo Briguori

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Chronic Kidney Disease

Presenter: Gregory P. Fontana, Saif Anwaruddin

November 01, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Yael L. Maxwell

October 06, 2017

News Daily News

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

Todd Neale

October 04, 2017

Advertisement

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Feasibility of PCI With No Contrast

Strategies to Optimize Hydration for CIN Prevention

Contrast Reduction Strategies in the Patient With CKD

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Contrast Induced Nephropathy: Why Does It Matter?

TAVR for Severe AS and Chronic Kidney Disease

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content